Notably, SH‐BC‐893 was also more effective than leflunomide at producing a tubulated mitochondrial network in cancer cells with activated KRAS, a model system where leflunomide has been shown to have antineoplastic activity (Yu et al, 2019). The gene discussed is KRAS; the disease is cancer.